ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984